Page last updated: 2024-12-06

calcium bromide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

calcium bromide: can cause skin injuries [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5360316
CHEMBL ID2105852
CHEBI ID31338
MeSH IDM0292053

Synonyms (24)

Synonym
AKOS015832992 ,
calcium dibromide
CHEBI:31338 ,
kalziumbromid
cabr2
calcium bromide
7789-41-5
87cny2eebh ,
NCGC00255890-01
dtxcid8024577
dtxsid0044577 ,
cas-7789-41-5
tox21_301859
CHEMBL2105852 ,
FT-0623380
calcium bromide [who-dd]
calcium bromide [mi]
WGEFECGEFUFIQW-UHFFFAOYSA-L ,
calciumbromidedihydrate
calciumbromide
brocal
Q409739
h-pro-pnahbr
calcium bromide, anhydrous (99.5%-ca)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The three tested concentrations of CaCl2 (240, 481, and 1925 mg L-1) caused a significant dose-response decrease of reproduction (p<0."( The effects of CaCl2 and CaBr2 on the reproduction of Daphnia magna Straus.
Hršak, V; Kovačević, G; Mažuran, N, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
calcium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.25)18.7374
1990's0 (0.00)18.2507
2000's6 (37.50)29.6817
2010's8 (50.00)24.3611
2020's1 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (10.53%)4.05%
Observational0 (0.00%)0.25%
Other17 (89.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]